NCT03919357

Brief Summary

The group of experts at HAS has defined the places of first and second-line workers in specific disorders of development and learning, as defined in the international diagnostic classifications International Classification of Diseases (CIM) CIM 11 and Diagnostic and Statistical Manual of Mental Disorders (DSM) DSM 5. The referral to a second-level structure, a multidisciplinary structure in charge of carrying out the different cognitive assessments, requires a preliminary evaluation. This orientation is based on a medical consultation, carried out by a doctor specialized in the field, with an exploration tool adapted to the different fields concerned. The BMTi, a battery of third-generation tests (after the Rapid battery of evaluation of the cognitive functions (BREV) and then the Evaluation of cognitive functions and learning of the child (EDA)) will enable the doctor, from 2018, to carry out this orientation in a relevant way in response to children with a complaint about neurodevelopment and learning. . The research project aims to validate this hypothesis, by comparing the diagnoses posed in a conventional way with the various multidisciplinary assessments, with the results of the transfer of all or part of the subtests of the BMTi by a doctor of second resort.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
229

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Typical duration for all trials

Geographic Reach
2 countries

16 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 7, 2019

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

April 4, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 18, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

May 20, 2021

Status Verified

May 1, 2021

Enrollment Period

2 years

First QC Date

April 4, 2019

Last Update Submit

May 19, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Sensitivity of BMT-i (modular computerized test battery)

    Calculation of the sensitivity of the BMT-i compared to the reference balance sheets

    3 months

  • Specificity of BMT-i

    Calculation of the specificity of the BMT-i compared to the reference balance sheets

    3 months

Secondary Outcomes (4)

  • Sensitivity and specificity of the BMT-i by type of complaint

    3 months

  • Kappa de Cohen test between BMTi assessments and the reference assessments

    3 months

  • Concordance between investigators evaluations and reviewers evaluations

    3 months

  • Curves ROC (Receiver operating characteristic)

    3 months

Study Arms (4)

Verbal

Passing of a specialized questionnaire on verbal disorders

Behavioral: BMT-i

Non-verbal

Passing of a specialized questionnaire on non verbal disorders

Behavioral: BMT-i

Attention

Passing of a specialized questionnaire on attention disorders

Behavioral: BMT-i

Complaint about learning

Passing of a specialized questionnaire on learning disorders

Behavioral: BMT-i

Interventions

BMT-iBEHAVIORAL

Passing the BMT-i test

AttentionComplaint about learningNon-verbalVerbal

Eligibility Criteria

Age5 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children between 5 and 13 years old with a complex developmental and learning disorder

You may qualify if:

  • Child aged 5 to 13
  • Complex complaint affecting one of the different areas of development and learning
  • Affiliation to a social security scheme

You may not qualify if:

  • Diagnosis of intellectual development disorder of autism spectrum disorder and suspect or confirm
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

Cabinet du Dr Vurpillat-Almanza

Besançon, France

Location

Cabinet du Dr Piollet

Chamalières, France

Location

Cabinet du Dr Gelbert

Chambéry, 73000, France

Location

CH Versailles - André Mignot

Le Chesnay, France

Location

Centre Médical Pédiatrique Flammarion

Marseille, France

Location

Hôpital Saint Eloi - Montpellier

Montpellier, France

Location

Cabinet du Dr Kochert

Orléans, 45000, France

Location

Centre Paris Santé Réussite

Paris, 75020, France

Location

Cabinet du Dr Cahn-Sellem

Puteaux, 92800, France

Location

CHU de Rouen

Rouen, France

Location

Cabinet du Dr Reynaud

Saint-Denis, France

Location

Cabinet du Dr Willig

Toulouse, France

Location

Cabinet du Dr Pineau

Trélazé, France

Location

Cabinet du Dr Lubelski

Verrières-le-Buisson, France

Location

Cabinet du Dr Werner

Villeneuve-lès-Avignon, France

Location

Cabinet du Dr Dulorme

Le Lamentin, 97129, Martinique

Location

MeSH Terms

Conditions

Specific Learning DisorderDevelopmental Disabilities

Condition Hierarchy (Ancestors)

Learning DisabilitiesCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2019

First Posted

April 18, 2019

Study Start

March 7, 2019

Primary Completion

March 1, 2021

Study Completion

April 1, 2021

Last Updated

May 20, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations